Research analysts at Jefferies Financial Group began coverage on shares of COCHLEAR LTD/ADR (OTCMKTS:CHEOY) in a research report issued to clients and investors on Monday, The Fly reports. The brokerage set a “hold” rating on the stock.
Separately, Citigroup lowered shares of COCHLEAR LTD/ADR from a “neutral” rating to a “sell” rating in a research note on Wednesday, July 17th.
Shares of COCHLEAR LTD/ADR stock opened at $73.42 on Monday. The company has a 50-day moving average of $70.99 and a 200 day moving average of $70.38. COCHLEAR LTD/ADR has a 1 year low of $56.58 and a 1 year high of $78.37.
About COCHLEAR LTD/ADR
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories.
Recommended Story: Average Daily Trade Volume – What It Means In Stock Trading
Receive News & Ratings for COCHLEAR LTD/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COCHLEAR LTD/ADR and related companies with MarketBeat.com's FREE daily email newsletter.